Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
733.67M | 703.63M | 836.52M | 782.36M | 626.72M | 395.52M | Gross Profit |
240.88M | 286.32M | 304.71M | 253.31M | 198.97M | 98.81M | EBIT |
163.59M | 74.43M | 148.61M | 148.97M | 93.71M | 54.24M | EBITDA |
143.84M | 98.87M | 170.51M | 167.08M | 117.00M | 67.20M | Net Income Common Stockholders |
117.79M | 34.66M | 107.47M | 109.46M | 91.31M | 40.34M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
25.27M | 25.27M | 18.39M | 47.89M | 21.57M | 21.66M | Total Assets |
1.41B | 1.41B | 1.39B | 1.16B | 1.04B | 366.57M | Total Debt |
214.20M | 214.20M | 301.86M | 241.96M | 240.40M | 42.93M | Net Debt |
188.93M | 188.93M | 283.47M | 194.07M | 218.83M | 21.27M | Total Liabilities |
573.24M | 573.24M | 543.28M | 412.57M | 397.20M | 104.05M | Stockholders Equity |
832.54M | 834.17M | 850.49M | 745.64M | 644.26M | 262.53M |
Cash Flow | Free Cash Flow | ||||
36.69M | 31.10M | 28.52M | 43.61M | 40.87M | 33.55M | Operating Cash Flow |
83.83M | 102.28M | 83.78M | 88.94M | 88.26M | 53.26M | Investing Cash Flow |
-31.87M | -71.56M | -159.24M | -47.81M | -182.62M | -19.65M | Financing Cash Flow |
-51.72M | -23.80M | 45.92M | -14.76M | 94.29M | -15.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $12.09B | 11.15 | 8.54% | 3.00% | -0.64% | 22.45% | |
70 Outperform | $16.39B | 16.49 | 27.99% | 2.55% | -5.11% | 3.64% | |
70 Outperform | $16.39B | 16.64 | 27.99% | 2.53% | -5.11% | 3.64% | |
63 Neutral | $656.62M | 19.82 | 4.07% | 1.55% | -15.89% | -68.54% | |
62 Neutral | $20.59B | 13.94 | -10.15% | 7.39% | 1.47% | 7.35% | |
61 Neutral | $2.57B | 46.28 | 5.99% | ― | 0.21% | -20.69% | |
61 Neutral | $32.77B | 48.55 | 7.94% | 2.23% | 3.69% | -55.78% |
On March 11, 2025, MGP Ingredients, Inc. announced a redesign of its annual long-term incentive program, incorporating performance stock units with financial performance goals and time-vested restricted stock units to motivate future service and performance. This new program aims to align the company’s compensation practices with industry standards and enhance its ability to retain and incentivize key personnel, potentially impacting its operational effectiveness and market competitiveness.
Members of the Board of Directors at MGP Ingredients, Inc., including Donn Lux, Karen Seaberg, and Lori Mingus, are planning to sell shares of the company’s common stock. These sales, which are part of their long-term financial and estate planning, do not indicate any lack of confidence in the company’s strategic vision or growth prospects, as the directors maintain significant equity stakes.
On February 12, 2025, MGP Ingredients’ Board of Directors approved updated terms for their Short Term Incentive Plan (STIP), effective January 1, 2025. This plan aims to motivate employees through performance-based incentive awards. Key details include eligibility for executive officers and certain non-union employees, the creation of a cash bonus pool based on company performance, and provisions for payouts in cases of termination due to death, disability, or change in control. The STIP aligns employee incentives with company performance, potentially enhancing operational efficiency and employee satisfaction.
MGP Ingredients, Inc. has announced leadership changes with Brandon Gall appointed as Interim President and CEO, succeeding David Bratcher, who will retire. Donn Lux will become Chairman of the Board, succeeding Karen Seaberg, as the company seeks a permanent CEO to steer its growth in the branded spirits industry. The company reaffirms its 2024 sales and earnings guidance, with capital expenditures adjusted due to delays in construction. These changes are poised to impact MGP’s strategic initiatives and strengthen its position in the market.